Library · reviewed November 2026
Sixteen compounds. Four evidence labels.
Sixteen of the compounds people ask about most. This is a teaching list, not a menu of products. Open any brief for what it is, what it has been studied for, and what the human record does not show. Each page has a slot for a 15-second vertical explainer.
“Studied for” describes the research question, not a proven result in people. We do not sell peptides and we do not give doses.
Human trial
Semaglutide
- Target tissue
- Gut–brain incretin signaling (appetite and metabolic pathways)
- Studied for
- Type 2 diabetes and obesity in large, published randomized trials.
Tirzepatide
- Target tissue
- Gut–brain incretin signaling (GLP-1 and GIP pathways)
- Studied for
- Type 2 diabetes and obesity in large, published randomized trials.
Tesamorelin
- Target tissue
- Visceral fat, via the growth-hormone axis
- Studied for
- Reducing visceral fat in a specific approved indication, with formal human trial data.
SS-31
- Target tissue
- Mitochondrial inner membrane
- Studied for
- Mitochondrial membranes, as a formal rare-disease programme. Confirm the current label before treating the approval point as settled.
GHK-Cu
- Target tissue
- Skin (collagen) and hair follicles
- Studied for
- Collagen, skin and hair. There is more topical and cosmetic human use than for most research peptides; large trial numbers were not extracted in our review.
MOTS-c
- Target tissue
- Muscle mitochondria and metabolic pathways
- Studied for
- Exercise-mimetic metabolic signaling. The biology is strong; human intervention trials are still limited.
Retatrutide
- Target tissue
- Metabolic signaling (GLP-1, GIP and glucagon pathways)
- Studied for
- Weight and metabolic outcomes as a triple agonist, in earlier-stage human trials than the approved GLP-1 medicines.
CJC-1295
- Target tissue
- The pituitary growth-hormone axis
- Studied for
- Growth-hormone and IGF-1 signaling in small human studies. It is not an FDA-approved medicine, and there are no large outcome trials.
Semax
- Target tissue
- Cortical and prefrontal networks; attention and cognition research
- Studied for
- Attention, focus, and brain research, mostly in Russian studies. Approved as a nasal medicine in Russia. Not FDA-approved.
BPC-157
- Target tissue
- Tendon, ligament, muscle and the gut lining
- Studied for
- Tissue repair in animal models. A published human randomized trial showing faster healing has not been shown.
TB-500
- Target tissue
- Muscle and connective tissue; proposed effects on blood-vessel growth
- Studied for
- Tissue repair in laboratory and animal models.
Dihexa
- Target tissue
- Hippocampal synapses and memory research
- Studied for
- Memory and synapse research in animal and laboratory models. A published human trial of dihexa itself has not been shown.
KPV
- Target tissue
- The intestinal lining and inflammatory signaling
- Studied for
- Gut inflammation in laboratory cells and mouse models. A published human trial has not been shown.
FOXO4-DRI
- Target tissue
- Senescent cells in laboratory cultures and mouse aging models
- Studied for
- Senescent-cell and aging research in laboratory cultures and mice. A published human trial has not been shown.
5-Amino-1MQ
- Target tissue
- Adipose and metabolic enzyme pathways. This one is a small-molecule compound, not a peptide.
- Studied for
- Metabolism in mice and in the lab. A published human trial has not been shown.
Pinealon
- Target tissue
- Brain tissue and pineal-associated research
- Studied for
- Sleep and neuroprotection discussions. The measured human report in our library is a single self-test of sleep staging, not a trial.
No peptides in this library match that filter.